Thermo Fisher Scientific Signs Agreement to Sell its Anatomical Pathology Business . WALTHAM, Mass., Jan. 28, 2019 / PRNewswire / -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has signed a definitive agreement to sell its Anatomical Pathology business to PHC Holdings Corporation , a global innovator in healthcare solutions, for approximately $1.14 billion in cash.What does Thermo Fisher make?
Thermo Fisher is an American biotechnology company that creates genetic testing and laboratory equipment. The company used AWS to build the Thermo Fisher Cloud, a platform that helps medical researchers and scientists securely store, analyze, and share data globally.What is Fisher services?
Fisher brand caliper. Fisher Scientific International, Inc. (NYSE: FSH) (colloquially known as Fisher) was a laboratory supply and biotechnology company that provided products and services to the global scientific research and clinical laboratory markets until its merger with Thermo Electron in 2006.